Anti‐apoptosis proteins such as BCL‐2 are up‐regulated via the activation of the NF‐κB pathway during the emergence of chemoresistance in invasive pancreatic cancer [33]. The gene discussed is NFKB1; the disease is pancreatic neoplasm.